SIRT1 and cancer: The activation of AMPK promotes autophagy and mitochondrial biogenesis by inhibiting mTOR, while SIRT1 inhibits the nuclear factor kappa-light chain enhancer of activated B cells (NF-κB), resulting in anti-inflammatory and anti-cancer effects.